 |
|
|
 |
Lack of awareness about stroke hinders use of life-saving drugs, precludes testing of new therapies
A widespread lack of public awareness about stroke prevents the delivery of leading-edge therapies and hampers the efforts of researchers to test the next generation of clot-busting drugs, said Dr. Hal Unwin, associate professor of neurology at UT Southwestern Medical Center at Dallas.
more
|
|
Off-label use of migraine drug gives children relief, study says
A new study suggests that when over-the-counter medications fail to help children who suffer from chronic migraine headaches, those children may find relief with a drug traditionally prescribed to adults. more
|
|
Pooled anaysis of SPORTIF III and V trials detailed at the American College of Cardiology annual meeting
Researchers at Mount Sinai School of Medicine announced an analysis of pooled data from two Phase III stroke prevention trials today at the American College of Cardiology (ACC) annual meeting in New Orleans, Louisiana. Pooled data demonstrated that ximelagatran, a new type of anti-clotting medication currently under FDA review, is as effective as current treatment warfarin for the prevention of stroke and systemic embolic events in men and women with nonvalvular atrial fibrillation (AF).
more
|
|
|
|
Diets high in fat and animal protein linked to increased risk of non-Hodgkin's lymphoma
Consuming foods high in animal protein, saturated fat, eggs and dairy leads to an increased risk of developing non-Hodgkin's lymphoma (NHL), a cancer that attacks the lymphatic system, part of the body's immune system, Yale researchers have found.
more
|
|
Hospitals following heart attack guidelines have better outcomes
In one of the first studies of its kind, Duke University Medical Center researchers have demonstrated clearly that hospitals' adherence to national guidelines for treating potential heart attacks saves lives. more
|
|
Evidence suggests that the brain can switch to 'automatic pilot' during learning
New studies suggest that humans might prefer to switch their brains to automatic pilot whenever possible to conserve their cogitating resources.
more
|
|
FDA approves first in a new class of drugs to treat hyperparathyroidism associated with renal failure and in patients with parathyroid cancer
FDA has approved Sensipar (cinacalcet), a drug to treat secondary hyperparathyroidism
in patients with chronic kidney disease on dialysis, and hypercalcemia in patients
with parathyroid cancer. more
|
|
|
